Cannabics Pharmaceuticals Stock Market Value
| CNBX Stock | USD 0.01 0 31.58% |
| Symbol | Cannabics |
Cannabics Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cannabics Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cannabics Pharmaceuticals.
| 12/26/2024 |
| 01/25/2025 |
If you would invest 0.00 in Cannabics Pharmaceuticals on December 26, 2024 and sell it all today you would earn a total of 0.00 from holding Cannabics Pharmaceuticals or generate 0.0% return on investment in Cannabics Pharmaceuticals over 30 days. Cannabics Pharmaceuticals is related to or competes with Biomx, Ascletis Pharma, Clearmind Medicine, Coeptis Therapeutics, and Quoin Pharmaceuticals. CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of ... More
Cannabics Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cannabics Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cannabics Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0512 | |||
| Maximum Drawdown | 96.67 | |||
| Value At Risk | (15.00) | |||
| Potential Upside | 7.04 |
Cannabics Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cannabics Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cannabics Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Cannabics Pharmaceuticals historical prices to predict the future Cannabics Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0563 | |||
| Jensen Alpha | 0.6712 | |||
| Total Risk Alpha | 0.0154 | |||
| Treynor Ratio | 1.29 |
Cannabics Pharmaceuticals Backtested Returns
Cannabics Pharmaceuticals appears to be out of control, given 3 months investment horizon. Cannabics Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0556, which signifies that the company had a 0.0556 % return per unit of risk over the last 3 months. By analyzing Cannabics Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.71% is justified by implied risk. Please makes use of Cannabics Pharmaceuticals' Standard Deviation of 12.69, risk adjusted performance of 0.0563, and Mean Deviation of 4.75 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Cannabics Pharmaceuticals holds a performance score of 4. The firm shows a Beta (market volatility) of 0.54, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cannabics Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cannabics Pharmaceuticals is expected to be smaller as well. Please check Cannabics Pharmaceuticals' variance, potential upside, as well as the relationship between the Potential Upside and day median price , to make a quick decision on whether Cannabics Pharmaceuticals' price patterns will revert.
Auto-correlation | -0.32 |
Poor reverse predictability
Cannabics Pharmaceuticals has poor reverse predictability. Overlapping area represents the amount of predictability between Cannabics Pharmaceuticals time series from 26th of December 2024 to 10th of January 2025 and 10th of January 2025 to 25th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cannabics Pharmaceuticals price movement. The serial correlation of -0.32 indicates that nearly 32.0% of current Cannabics Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.32 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cannabics Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Cannabics Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cannabics Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Cannabics Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Cannabics Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cannabics Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cannabics Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cannabics Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cannabics Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Cannabics Pharmaceuticals Lagged Returns
When evaluating Cannabics Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cannabics Pharmaceuticals pink sheet have on its future price. Cannabics Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cannabics Pharmaceuticals autocorrelation shows the relationship between Cannabics Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Cannabics Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cannabics Pink Sheet Analysis
When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.